Enanta Pharmaceuticals Inc.
- Address
- 4 Kingsbury Avenue
Sponsor Overview
Specializations
Respiratory syncytial virus infection
Clinical research activity is centered on RSV in non-hospitalized adults, with attention to acute infection and the risk of complications in higher-risk populations.
- Acute respiratory infection
- Complication risk in adults
- Outpatient viral illness
The sponsor’s current research focus is directed toward clinical outcomes linked to symptom progression during respiratory syncytial virus infection.
Respiratory medicine
The trial portfolio reflects interest in respiratory tract infection management, particularly conditions affecting symptomatic burden and disease progression in adults outside the hospital setting.
- Lower respiratory tract disease
- Symptom assessment
- Adult respiratory care
Medical interest is concentrated on clinical endpoints relevant to pulmonary infection and the course of viral respiratory illness.
Antiviral therapeutics
Research activity includes evaluation of a targeted antiviral approach for RSV, with emphasis on therapeutic impact in infected adults at elevated risk.
- Viral replication control
- Treatment of acute viral disease
- Supportive symptom relief
The therapeutic domain is focused on medicines intended to alter the clinical course of viral infection rather than broad infectious-disease programs.
Infectious disease outcomes
Clinical interest extends to measurable outcomes associated with infectious disease, including symptom change and progression of illness in adults with confirmed RSV infection.
- Clinical symptom progression
- Disease course monitoring
- Risk stratification
The funded research examines how treatment may influence the trajectory of acute viral respiratory disease in a community-based setting.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of EDP-938 (Zelicapavir) Efficacy and Safety in Non-Hospitalized Adults with Acute Respiratory Syncytial Virus Infection at High Risk for Complications |  Bulgaria Czechia Poland Slovakia Spain The Netherlands | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 34 sites across their trial portfolio.
Therapeutic Focus
- 1.Respiratory Tract Diseases1 trial277 other sponsors
Partnered Research Centres
34 centres- Address
- Pck 26 Street, 33-100 Tarnow
- Address
- Avenida De Gonzalez Meneses S/n, 14940 Cabra
- Address
- Ul. Ul. Jana Dlugosza 4, 51-162 Wroclaw
- Address
- ul. Stefana 2, 91-463 Lodz
- Address
- Ulitsa Todor Kableshkov 2, 3600 Lom
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Enanta Pharmaceuticals Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.